As of May 2022 Mesoblast has a market cap of $0.46 Billion. This makes Mesoblast the world's 5036th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.45 B | -31% |
2021 | $0.66 B | -34.9% |
2020 | $1.01 B | 30.05% |
2019 | $0.78 B | 92.31% |
2018 | $0.40 B | -24.07% |
2017 | $0.53 B | 36.85% |
2016 | $0.39 B | -23.6% |
2015 | $0.51 B | -56.03% |
2014 | $1.16 B | -28.73% |
2013 | $1.63 B | 69.86% |
2012 | $0.96 B | -11.09% |
2011 | $1.08 B | 47.28% |
2010 | $0.73 B | 341.55% |
2009 | $0.16 B | 99.5% |
2008 | $0.08 B |
On May 21st, 2022 the market cap of Mesoblast was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | $0.11 B | -75.29% | Bahamas |